ARCHIVES

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Antman Is President Elect; Minorities More Likely To Get Worse Care, IOM Finds

April 12, 2002

In Congress: Senate Passes Bill For DOD Medical Research Funding

August 14, 1998

Authorizes $2.7 Billion For NCI, 7% Prevention

May 28, 1993

Kennedy, Hutchison Introduce Long-Awaited Bill To Reauthorize The National Cancer Program

April 3, 2009

In Brief: Angel Bradley, NCAB Member, Dies; Three State Colorectal Cancer Screening Effort Big Success

July 5, 1985